Jpmorgan Chase & CO 23and Me Holding Co. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in 23and Me Holding Co. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 42,980 shares of ME stock, worth $202,006. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,980

Previous 192,664 77.69%

Holding current value

$202,006

Previous $102,000 84.31%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$0.36 - $0.61 $53,886 - $91,307	-149,684 Reduced 77.69%	42,980 $16,000
Q1 2024 May 10, 2024	SELL	$0.4 - $0.91 $27,408 - $62,353	-68,520 Reduced 26.23%	192,664 $102,000
Q4 2023 Feb 12, 2024	SELL	$0.71 - $0.97 $103,566 - $141,492	-145,869 Reduced 35.84%	261,184 $237,000
Q3 2023 Nov 14, 2023	BUY	$0.96 - $2.01 $12,520 - $26,214	13,042 Added 3.31%	407,053 $398,000
Q2 2023 Aug 11, 2023	BUY	$1.59 - $2.29 $59,869 - $86,227	37,654 Added 10.57%	394,011 $689,000
Q1 2023 May 18, 2023	BUY	$2.05 - $2.87 $695,462 - $973,647	339,250 Added 1983.11%	356,357 $812,000
Q1 2023 May 11, 2023	SELL	$2.05 - $2.87 $553,463 - $774,848	-269,982 Reduced 94.04%	17,107 $39,000
Q4 2022 Feb 13, 2023	BUY	$2.06 - $3.47 $64,545 - $108,725	31,333 Added 12.25%	287,089 $620,000
Q3 2022 Nov 14, 2022	BUY	$2.6 - $5.12 $184,883 - $364,078	71,109 Added 38.51%	255,756 $732,000
Q2 2022 Aug 11, 2022	BUY	$2.19 - $3.98 $215,793 - $392,173	98,536 Added 114.43%	184,647 $458,000
Q1 2022 May 11, 2022	BUY	$3.28 - $7.12 $128,136 - $278,149	39,066 Added 83.04%	86,111 $330,000
Q4 2021 Feb 10, 2022	BUY	$6.55 - $13.25 $207,431 - $419,614	31,669 Added 205.96%	47,045 $314,000
Q3 2021 Nov 12, 2021	BUY	$7.29 - $11.0 $112,091 - $169,136	15,376 New	15,376 $139,000

Others Institutions Holding ME

# of Institutions

150

Shares Held

99.9M

Call Options Held

270K

Put Options Held

349K

View Full List

About 23andMe Holding Co.

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $1.22B
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

More about ME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO 23and Me Holding Co. Transaction History